Table 1 Experiments included in the meta-analysis of Alzheimer’s disease: clinical, socio-demographic, and methodological data.

From: Evaluating the robustness of DTI-ALPS in clinical context: a meta-analytic parallel on Alzheimer’s and Parkinson’s diseases

Experiment

Scanner Tesla

Directions

b-Value s/mm2

Alzheimer’s disease

Healthy controls

DTI-ALPS results

No. subjects (male)

Age (SD)

MMSE (SD)

No. subjects (male)

Age (SD)

DTI-ALPS AD (SD)

Alps L AD (SD)

Alps R AD (SD)

DTI-ALPS HC (SD)

Alps L HC (SD)

Alps R HC (SD)

Taoka et al., 20174

3.0

30

1000

16 (Na)

75 (Na)

Na

6 (Na)

Na

1.2 (0.19)

1.2 (0.19)

Na

1.4 (0.23)

1.4 (0.23)

Na

Hsu et al., 202219

Na

64

1000

37 (10)

63.2 (4.7)

17.7 (6.7)

13 (4)

61 (7.1)

1.4 (0.2)

1.4 (0.2)

Na

1.5 (0.1)

1.5 (0.1)

Na

Zhang et al., 202420

3.0

104

1000

15 (9)

66.9 (9.5)

9.5 (7.6)

26 (11)

63.4 (7.4)

1.42 (0.16)

1.4 (0.16)

1.45 (0.19)

1.57 (0.16)

1.56 (0.18)

1.59 (0.18)

Ota et al., 202221

3.0

30

1000

21 (7)

71.3 (9.1)

20.8 (3)

36 (15)

64.6 (7.6)

1.19 (0.14)

1.2 (0.15)

1.18 (0.15)

1.39 (1.16)

1.38 (0.19)

1.4 (0.18)

Matsushita et al., 202422

3.0

64

1000

29 (14)

78.3 (6.8)

24.1 (4.4)

29 (14)

78.3 (6.8)

1.3 (0.1)

Na

Na

1.4 (0.1)

Na

Na

Liang et al., 202323

3.0

Na

1000

38 (10)

72.05 (6.95)

17.71 (5.34)

28 (11)

67.75 (6.09)

1.15 (0.07)

1.15 (0.07)

Na

1.44 (0.07)

1.44 (0.07)

Na

Steward et al., 202124

3.0

30

1000

16 (11)

69.13 (Na)

18.7 (Na)

10 (5)

73.8 (Na)

1.47 (Na)

1.58 (0.16)

1.5 (0.14)

1.53 (Na)

1.48 (0.17)

1.6 (0.23)

Zhong et al., 202325

3.0

64

2000

36 (17)

74.8 (8)

14.9 (5.5)

65 (30)

67.9 (6.5)

2.07 (0.22)

Na

Na

2.2 (0.2)

Na

Na

Kamagata et al., 202226

3.0

41

1000

36 (22)

74.28 (8.76)

23.39 (1.96)

31 (14)

73.86 (4.91)

1.24 (0.21)

Na

Na

1.34 (0.11)

Na

Na

Chang et al., 202327

3.0

64

1000

130 (52)

60.15 (3.67)

19.55 (7.77)

130 (60)

58.52 (5.71)

0.99 (0.06)

Na

Na

1.02 (0.05)

Na

Na

Saito et al., 202328

3.0

41

1000

25 (25)

75.4 (6.9)

23.4 (1.9)

29 (29)

73.7 (7.5)

1.47 (Na)

1.5 (0.28)

1.43 (0.22)

1.535 (Na)

1.55 (0.22)

1.52 (0.19)

Saito et al., 202328

3.0

41

1000

11 (11)

75 (6)

23.4 (2.1)

14 (14)

74.9 (7.8)

1.39 (Na)

1.37 (0.19)

1.41 (0.2)

1.55 (Na)

1.56 (0.24)

1.54 (0.19)

Saito et al., 202328

3.0

48

1000

9 (9)

74 (5.5)

23.5 (1.5)

39 (39)

74.2 (7.2)

1.41 (Na)

1.39 (0.17)

1.43 (0.22)

1.525 (Na)

1.52 (0.23)

1.53 (0.21)

  1. AD = Alzheimer’s disease; DTI-ALPS = diffusion tensor image analysis along the perivascular space; HC = healthy controls; L = left; MMSE = Mini-Mental State Examination; Na = data not associated; R = right; SD = standard deviation.